Consonance Sp Z Oo

Consonance Sp. z o.o., established on March 25, 2019, is a Kraków-based medical device development company specializing in transforming innovative ideas into reliable healthcare solutions. With a team of 20-49 professionals, the company offers comprehensive services encompassing prototyping, engineering, manufacturing, regulatory consulting, and artificial intelligence integration for medical devices. Their expertise spans various medical fields, including cardiology, diabetes, obstetrics and gynecology, pain relief, and rehabilitation. Consonance collaborates with startups, MedTech companies, and pharmaceutical multinationals to bring cutting-edge medical technologies to market.

Company Overview

Consonance operates as a private limited liability company (Sp. z o.o.) under Polish law, with its registered office located at Ul. Wojciecha Weissa 7, 31-339 Kraków, Poland. The company is VAT-registered under the number PL6772442830 and is listed in the Krajowy Rejestr Sądowy (KRS) with the number 0000778440. The firm’s primary activity involves research and development in the physical, engineering, and life sciences, excluding nanotechnology and biotechnology. Secondary activities include manufacturing audio and video equipment, semiconductor components, and electronic instruments.

Leadership and Team

At the helm of Consonance is Mariusz Mateusz Mąsior, serving as the Chairman of the Management Board. Mariusz brings a wealth of experience as a full-stack developer and engineer, with a background in system architecture and engineering. He has previously conducted research at the AGH University of Science and Technology in Digital Signal Processing, Speech Technology, and System Engineering. His academic pursuits also led him to positions as a visiting scholar at Stanford University and the Nagoya Institute of Technology. Under his leadership, Consonance has cultivated a team of skilled professionals, including engineers, scientists, and regulatory experts, all dedicated to advancing medical technology.

Services Offered

Consonance provides a suite of services tailored to the needs of the MedTech industry, ensuring that clients receive end-to-end support in developing medical devices.

• PrototypingDeveloping initial models to test and refine concepts.
• EngineeringApplying engineering principles to design functional and manufacturable devices.
• ManufacturingProducing medical devices in compliance with industry standards.
• Regulatory ConsultingAssisting with navigating the regulatory landscape to achieve necessary approvals.
• Artificial Intelligence IntegrationIncorporating AI to enhance device functionality and performance.

Industries Served

Consonance’s expertise extends across several key medical sectors, including

• CardiologyDeveloping devices for heart-related conditions.
• DiabetesCreating solutions for monitoring and managing blood sugar levels.
• Obstetrics and GynecologyInnovating tools for women’s health and prenatal care.
• Pain ReliefDesigning therapies to alleviate chronic pain.
• RehabilitationProducing devices to aid in physical recovery and mobility.

Notable Projects

Consonance has been instrumental in the development of several groundbreaking medical devices, including

• PREGNABIT PROA telemedical CTG device designed for both hospital and home use, facilitating remote monitoring of fetal health.
• TRU+A fast and non-invasive pain relief therapy device aimed at providing immediate relief.
• ONIRYAn impedance spectrometry device for postpartum diagnosis, enhancing postnatal care.

These projects showcase Consonance’s commitment to advancing healthcare through innovative technology.

Financial Performance

As of 2024, Consonance reported a turnover of 2,371,824 PLN, a decrease from the previous year’s 3,644,769 PLN. The company experienced a net loss of 464,552 PLN, reflecting challenges faced during the year. Despite these financial setbacks, Consonance maintains a liquidity ratio of 1.45, indicating a stable short-term financial position. The company’s equity stood at 364,628 PLN, with current liabilities amounting to 812,367 PLN.

Certifications and Compliance

Consonance holds ISO 134852016 certification, affirming its adherence to quality management systems for medical devices. This certification underscores the company’s commitment to meeting regulatory requirements and delivering high-quality products. Additionally, Consonance ensures that its developments comply with the Medical Device Regulation (MDR) and the U.S. Food and Drug Administration (FDA) standards, facilitating market access in both European and North American regions.

Client Testimonials

Clients have praised Consonance for its expertise and collaborative approach. For instance, Lisbeth Moller Christensen, QA Manager at BrainCapture, commended the company for its technical and regulatory knowledge, stating that Consonance delivered on time, quality, and price without deviation. Similarly, Katarzyna Borycka-Kiciak, CEO of OASIS Diagnostics, highlighted the company’s excellent project management and communication throughout the development of the ONIRY product.

Contact Information

For more information or inquiries, Consonance can be contacted at

• Phone+48 790 261 534
• Emailoffice@consonance.tech
• AddressUl. Wojciecha Weissa 7, 31-339 Kraków, Poland

Consonance continues to be a key player in the medical device development sector, leveraging its expertise to bring innovative healthcare solutions to life.